The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, requires a complex several-stage organic process. Initial routes focused on peptide section coupling, utilizing solid-phase synthesis methodologies to build the long amino acid sequence. Subsequent investigation has explored alternative approaches, including